SERPINE1 and pulmonary arterial hypertension: Sotatercept decreased the expression of plasminogen activator inhibitor (PAI)-1, a known target gene of the TGF-β pathway and suppressed the aggravation of hemodynamics and vascular remodeling in experimental animal models of PAH [14].